Stay updated on Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a software update rather than a change to study details.SummaryDifference0.0%

- Check11 days agoChange DetectedA new publication citation has been added to the study record, detailing the safety analysis of the FRESCO-2 trial in Oncologist (2025). The citation lists Eng C et al. and the article title related to fruquintinib versus placebo in refractory metastatic colorectal cancer.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded new navigation/help sections to the Study Details page (How to Read a Study Record, Common Questions, How to Join a Study) and updated the Intervention/Treatment header, while removing the older Intervention / Treatment label and the Revision: v3.5.5 tag. These changes affect how users navigate and understand the page rather than the study content.SummaryDifference0.2%

- Check26 days agoChange DetectedA new publication citation regarding Fruquintinib's cardiac safety in metastatic colorectal cancer was added to the study record. The revision version was updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4. This represents a minor update to the page's revision history.SummaryDifference0.0%

- Check62 days agoChange Detected**Revision updated** from v3.5.2 to v3.5.3, indicating an update to the page version for the study record. This reflects an updated revision of the page in ClinicalTrials.gov's version history.SummaryDifference0.0%

Stay in the know with updates to Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.